MurphyW.M.Diseases of the urinary bladder, urethra, ureters, and renal pelves. In: MurphyW.M., ed. Urological Pathology.Philadelphia, Pa: WB Saunders Co; 1989: 64–68, 89–94, 94–97, 97–100.
2.
KunzeE., SchauerA., SchattS.Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl) nitrosamine-induced transitional cell carcinoma in the urinary bladder of the rats. Z Krebsforsch.1976; 87: 139–160.
3.
KossL.G.Mapping of the urinary bladder: its impact on the concepts of bladder cancer. Hum Pathol.1979; 10: 533–548.
4.
MurphyW.M., RamseyJ., SolowayM.S.A better nuclear fixative for diagnostic bladder and prostate biopsies. J Urol Pathol.1993; 1: 79–87.
5.
MurphyW.M., BeckwithJ.B., FarrowG.M.Tumors of the kidney, bladder, and related urinary structures, Fascicle #11 AFIP 3rd series.Washington, DC: 1994; 219–230.
6.
OrozcoR.E., MartinA.A., MurphyW.M.Carcinoma in situ of the urinary bladder: clues to host involvement in human carcinogenesis. Cancer.1994; 74: 115–122.
7.
OrozcoR.E., Vander ZwaagR., MurphyW.M.The pagetoid variant of urothelial carcinoma in situ. Hum Pathol.1993; 24: 1199–1202.
8.
CoonJ.S., McCallA., MillerA.W.Expression of blood-group-related antigens in carcinoma in situ of the urinary bladder. Cancer.1985; 564: 797–804.
9.
SpruckCH3rd, OhneseitP.F., Gonzalez-ZuluetaM.Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res.1994; 54: 784–788.
